MONLUNABANT

UNII:	4G8X27X87A
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₆H₂₂ClF₃N₆O₃S
Preferred Substance Name:	MONLUNABANT
InChIKey:	GYJPQNPVIJXXTA-JOCHJYFZSA-N
GSRS Full Record:	4G8X27X87A i

2712480-46-9
(4S)-3-(4-chlorophenyl)-4,5-dihydro-N′-(acetylamino(imino)methyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide
Acetamide, N-[[[[(4S)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[[4-(trifluoromethyl)phenyl]sulfonyl]amino]methylene]amino]iminomethyl]-
MRI-1891
MRI-1891, (S)-
Monlunabant
Monlunabant [WHO-DD]
N-[N'-[C-[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-N-[4-(trifluoromethyl)phenyl]sulfonylcarbonimidoyl]carbamimidoyl]acetamide
N-[N'-[C-[(4S)-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-N-[4-(trifluoromethyl)phenyl]sulfonylcarbonimidoyl]carbamimidoyl]acetamide
monlunabant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MONLUNABANT

Synonyms and Mappings

Resources